Tender detail
Open-house drug rebate agreements for atropine-containing medicines
Summary
The procurement concerns non-exclusive rebate agreements for medicines containing atropine (ATC S01FA01), covering the period from 1 January 2027 to 31 December 2028. Under the open-house model, agreements may be concluded at any time during that period. Medicines included on the BfArM list of children’s medicines under Section 35(5a) of SGB V are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.